The patient received antibiotics and pain medication.Per product labeling: the action of oral anticoagulants (coumarin derivatives) can be increased or weakened when other medication is taken simultaneously (e.G.Antibiotics, but also prescription-free medication like pain relievers, antirheumatic medication, and medication against influenza).This, in turn, can also lead to either an increase or a decrease in prothrombin time (inr).The meter and strips have been requested for return.The product has not been received at this time.If the product is returned in the future, a follow-up report will be submitted.On a regular basis, coaguchek strips of lots currently valid in the market are tested as part of routine retention testing and results have passed the internal inspection.Per product labeling, "coaguchek uses human recombinant thromboplastin.Therefore, the comparability to other human recombinant thromboplastins is best, whereas higher deviations can occur with other thromboplastins.However, those higher differences between thromboplastins of different (rabbit, bovine based) origin are not a coaguchek specific issue.Similar differences can be observed when a human recombinant thromboplastin-based laboratory method is compared against several other (rabbit, bovine-based) laboratory methods." e3 - occupation was patient/consumer h3 other text.
|
There was an allegation of questionable results from a coaguchek xs meter.The serial number was not provided.At 10:00 am, the result from a laboratory using an unknown reagent was 2.3 inr.At 10:30 am, the result from the meter was 4.4 inr.The therapeutic range was 2.5-3.0 inr.
|